Groundbreaking dual-action molecule propels OLED screens and cutting-edge medical imaging technology forward globally
Researchers at Kyushu University have developed a groundbreaking organic molecule named CzTRZCN, which acts as a versatile "switch" for next-generation screens and high-precision medical imaging [1][3][5]. This molecule, through its unique properties, could potentially revolutionise consumer electronics and biomedical diagnostics.
CzTRZCN is a combination of an electron-rich carbazole unit and an electron-deficient triazine core, with cyano groups modifying the structure. This design allows the molecule to switch between a twisted structure, optimal for light emission via thermally activated delayed fluorescence (TADF), and a planar structure that facilitates strong light absorption through two-photon absorption (2PA) [1].
In the realm of Organic Light Emitting Diodes (OLEDs), CzTRZCN demonstrated an impressive external quantum efficiency of 13.5%, a record for triazine-based TADF materials [1]. This efficiency is due to the molecule's ability to convert normally wasted triplet-state energy into light-emitting singlet states using ambient heat, a process known as TADF.
Meanwhile, in medical applications, CzTRZCN's ability to absorb two lower-energy photons at once, a technique known as two-photon absorption (2PA), allows for sharper, safer deep-tissue imaging by exciting only tissue at the laser's focal point [1]. The molecule showed a high 2PA cross-section and strong brightness, making it promising for medical imaging.
Moreover, the metal-free, low-toxicity nature of CzTRZCN makes it highly biocompatible, ideal for medical probes.
The discovery of CzTRZCN could pave the way for devices that bridge entertainment and healthcare, using one molecule to power brighter displays and enable safer, sharper diagnostics. The study outlines a strategy for creating molecules with different orbital arrangements for light absorption and emission [1].
The team plans to expand the design to cover more emission wavelengths and to collaborate with biomedical and device engineers to further explore the potential of this revolutionary molecule.
[1] https://www.nature.com/articles/s41565-022-01175-4 [3] https://www.nature.com/articles/s41598-022-06831-y [5] https://pubs.acs.org/doi/10.1021/acs.jpcc.2c04260
- The innovative organic molecule, CzTRZCN, has the potential to revolutionize not only consumer electronics through its application in Organic Light Emitting Diodes (OLEDs) but also health-and-wellness sectors, as its two-photon absorption (2PA) capacity allows for sharper, safer deep-tissue imaging.
- In the field of science and technology, the development of CzTRZCN by researchers at Kyushu University could spark advancements in both the innovation of next-generation screens and high-precision medical imaging, thanks to its unique properties and versatile switching mechanism.
- The groundbreaking molecule, CzTRZCN, with its combination of a carbazole unit and a triazine core, represents a significant leap forward in the realm of robotics and biomedical diagnostics, as its characteristics make it highly biocompatible for use in medical probes.
